Table 3.

Logistic regression model of baseline factors predictive of relapse frequency in EGPA. Values of p < 0.05 were considered statistically significant.

VariablesExponent95% CIp
Age at onset EGPA, yrs0.9790.946–1.0120.2
GI tract with both symptoms and abnormalities on endoscopy and biopsy3.9611.251–12.536< 0.05
Myocardial involvement with both symptoms and abnormalities on 1 or more cardiac investigations5.8051.901–17.729< 0.01
Central nervous system involvement0.6830.205–2.2790.54
Otitis media2.0080.589–6.8400.27
Minimum MMT score0.6680.343–1.3000.24
MPO-ANCA at onset, yes/no0.8180.254–2.6330.74
  • EGPA: eosinophilic granulomatosis with polyangiitis; MMT: manual muscle test; MPO-ANCA: myeloperoxidase-specific antineutrophil cytoplasmic antibody; GI: gastrointestinal.